Cover Image

Guidance for industry : analytical procedures and methods validation, chemistry, manufacturing, and controls documentation.

Bibliographic Details
Corporate Authors:	Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.)
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [2000]
Subjects:	Drugs > Testing > Documentation > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS120627

Similar Items

Guidance for industry : immediate release solid oral dosage forms : scale-up and postapproval changes, chemistry, manufacturing and controls, in vitro dissolution testing, and in vivo bioequivalence documentation.
Published: (1995)

Guidance for industry : nonsterile semisolid dosage forms : scale-up and postapproval changes : chemistry, manufacturing, and controls : in vitro release testing and in vivo bioequivalence documentation.
Published: (1997)

Guidance for industry : SUPAC-MR : modified release solid oral dosage forms : scale-up and postapproval changes, chemistry, manufacturing and controls, in vitro dissolution testing and in vivo bioequivalence documentation.
Published: (1997)

Guidance for industry : M2, eCTD specification, questions & answers and change requests.
Published: (2005)

Guidance for industry : liposome drug products, chemistry, manufacturing, and controls; human pharmacokinetics and bioavailablity; and labeling documentation.
Published: (2002)

Guidance for industry : photosafety testing.
Published: (2003)

Guidance for industry : nonclinical safety evaluation of drug or biologic combinations.
Published: (2006)

Guidance for industry : stability testing, photostability testing of new veterinary drug substances and medicinal products.
Published: (1999)

Guidance for industry : S1B testing for carcinogenicity of pharmaceuticals.
Published: (1997)

Guidance for industry : process validation, general principles and practices.
Published: (2008)

Guidance for industry : investigating out-of-specification test results (OOS) for pharmaceutical production.
Published: (2006)

Guidance for industry : CGMP for phase 1 investigational drugs.
Published: (2008)

Guidance for industry : PAC-ATLS : postapproval changes, analytical testing laboratory sites.
Published: (1998)

Guidance for industry : statistical aspects of the design, analysis, and interpretation of chronic rodent carcinogenicity studies of pharmaceuticals.
Published: (2001)

Guidance for industry : M2 eCTD : electronic common technical document specification.
Published: (2003)

Guidance for industry : Q1B photostability testing of new drug substances and products.
Published: (1996)

Guidance for industry : S7A safety pharmacology studies for human pharmaceuticals.
Published: (2001)

Guidance for industry : Q1A(R2) stability testing of new drug substances and products.
Published: (2003)

Guidance for industry : S8 immunotoxicity studies for human pharmaceuticals.
Published: (2006)

Guidance for industry : Q1D bracketing and matrixing designs for stability testing of new drug substances and products.
Published: (2003)

Guidance for industry : estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers.
Published: (2005)

Guidance for industry : Q1E evaluation of stability data.
Published: (2004)

Guidance for industry : nonclinical safety evaluation of pediatric drug products.
Published: (2006)

Guideline for submitting supporting documentation in drug applications for the manufacture of drug substances.
Published: (1987)

Guidance for industry : S6 preclinical safety evaluation of biotechnology-derived pharmaceuticals.
Published: (1997)

Guidance for industry : stability testing of new veterinary dosage forms.
Published: (1999)

Guidance for industry : tropical disease priority review vouchers.
Published: (2008)

Guidance for industry : drug-induced liver injury, premarketing clinical evaluation.
Published: (2007)

Guideline for submitting documentation for the manufacture of and controls for drug products.
Published: (1987)

Guidance for industry : handling and retention of BA and BE testing samples.
Published: (2004)

Guidance for industry and review staff : nonclinical safety evaluation of reformulated drug products and products intended for administration by an alternate route.
Published: (2008)

Guidance for industry : S1C(R2) dose selection for carcinogenicity studies.
Published: (2008)

Guidance for industry : E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs.
Published: (2005)

Guidance for industry : single dose acute toxicity testing for pharmaceuticals.
Published: (1996)

Guidance for industry : comparability protocols, chemistry, manufacturing, and controls information.
Published: (2003)

Guidance for industry : S2B genotoxicity, a standard battery for genotoxicity testing of pharmaceuticals.
Published: (1997)

Guidance for industry : Q3C impurities, residual solvents.
Published: (1997)

Guidance for industry : bioanalytical method validation.
Published: (2001)

Guidance for industry : Q4B evaluation and recommendation of pharmocopoeial texts for use in the ICH regions : annex 3 test for particulate contamination, subdivisible particles general chapter.
Published: (2009)

Guidance for industry : E 11 clinical investigation of medicinal products in the pediatric population.
Published: (2000)